Cancer is a package of diseases marked by uncurbed growth and proliferation of anomalous cells. The illness is generally assumed to be the fruit of the impact of assorted outside factors and inner forces, such as tobacco smoking, radiation exposure, chemicals’ influences, infectious agents, inherited gene mutations, hormonal disorders, immune system conditions and mutations of other origins, among others.
Thus far, the Cancer Market has already seen noticeable progress in early-stage tumor detection and cure globally. The market for Cancer diagnostics is close to explosive growth, promising to reach approximately EUR 4 billion in value by end-2015. Further, technology discoveries will continue to afford many chances of demystifying the genetic components of the sickness, identifying specific tumor types, and observing biological reaction to cancer treatments. However, the bulk of presently available therapies do not fully protect against some unwelcomed side-effects.
The research reports in this Catalogue present global, regional and nation-level analyses of the Cancer Market development trends over different time spans. The research reports identify major bizopps emerging in the Cancer Market; examine versatile Cancer diagnostic test technologies along with their applications, besides looking into other Cancer Market issues. The research reports also profile the top players and would-be entrants, as well as offer test volume and sales projections.
Publications found:
1,595
Sort by:
2015-2019 Cancer Diagnostics: A Market on the Verge of Explosion - Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence
US$ 19,600.00
... , sales forecasts, supplier shares) $15,900. 2015-2019 Cancer Diagnostics: A Market on the Verge of Explosion--Technological Breakthroughs, Emerging Tests, Market Forecasts, Competitive Intelligence is VPGMarketResearch's new study ... and market segment; profiles leading players and potential market entrants; and identifies specific business opportunities for suppliers. Rationale The cancer diagnostics market is on the ...
August 2015
1200 pages
Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015
US$ 3,000.00
... Cancer CD Antigens Inhibitors Therapy Market & Pipeline Insight 2015” Report Highlight: Nomenclature & Classification of CD Antigens Mechanism of CD Antigen Cancer Therapeutics Cancer CD Antigen Therapy Market Overview Cancer CD Antigen Inhibitors Clinical Pipeline by Company, Indication & Phase Cancer ...
August 2015
600 pages
Global Glaucoma Treatment Market - Trends And Opportunities: 2015 Edition
US$ 1,200.00
... “Global Glaucoma Treatment Market: Trends and Opportunities (2015 Edition)” analyzes the potential opportunities, challenges, demand drivers and significant trends representing the Glaucoma treatment market. The ... in registration trials for glaucoma, in two phase 3 studies. Globally, the major factors contributing to the growth of Glaucoma treatment market is the higher number of glaucoma patients from the ...
July 2015
80 pages
Global Breast Cancer Market Report: 2015 Edition
US$ 800.00
... to develop effective treatment methods for breast cancer. The present report provides a comprehensive analysis of the global breast cancer diagnosis and treatment market with focus on regions like ...
July 2015
64 pages
2015-2019 World Cancer Diagnostics Market: Emerging Tests, Technology Assessment, Instrumentation Review, Sales Forecasts by Country and Strategic Profiles of Leading Suppliers
US$ 6,000.00
... cancer diagnostics market, including emerging tests, technologies, instrumentation, sales forecasts by country, and strategic profiles of leading suppliers. The report presents: Estimated numbers of cancer ... significance and market needs for both current and emerging cancer diagnostic tests, as well as listings of companies, universities and research centers developing or marketing new ...
July 2015
510 pages
CompetitiveWatch Cancer Diagnostics 2015: Strategic Assessments of Major Suppliers
US$ 2,000.00
This report presents strategic analyses of major current and emerging suppliers of cancer diagnostic products in terms of their sales, market shares, product portfolios, distribution tactics, technological know-how, new products in R&D, collaborative arrangements and business strategies. Contains 80 pages
July 2015
80 pages